DK2010536T3 - Imidazo [1,2-B]pyridaziner, fremgangsmåde til deres fremstilling og deres anvendelse som GABA-receptor-ligander - Google Patents

Imidazo [1,2-B]pyridaziner, fremgangsmåde til deres fremstilling og deres anvendelse som GABA-receptor-ligander

Info

Publication number
DK2010536T3
DK2010536T3 DK07727460.3T DK07727460T DK2010536T3 DK 2010536 T3 DK2010536 T3 DK 2010536T3 DK 07727460 T DK07727460 T DK 07727460T DK 2010536 T3 DK2010536 T3 DK 2010536T3
Authority
DK
Denmark
Prior art keywords
pyridazines
imidazo
preparation
methods
receptor ligands
Prior art date
Application number
DK07727460.3T
Other languages
English (en)
Inventor
Jose Luis Falco
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK2010536T3 publication Critical patent/DK2010536T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07727460.3T 2006-03-29 2007-03-28 Imidazo [1,2-B]pyridaziner, fremgangsmåde til deres fremstilling og deres anvendelse som GABA-receptor-ligander DK2010536T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06111899A EP1845098A1 (en) 2006-03-29 2006-03-29 Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
PCT/EP2007/052988 WO2007110437A1 (en) 2006-03-29 2007-03-28 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands

Publications (1)

Publication Number Publication Date
DK2010536T3 true DK2010536T3 (da) 2010-10-04

Family

ID=36323447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07727460.3T DK2010536T3 (da) 2006-03-29 2007-03-28 Imidazo [1,2-B]pyridaziner, fremgangsmåde til deres fremstilling og deres anvendelse som GABA-receptor-ligander

Country Status (22)

Country Link
US (2) US8153789B2 (da)
EP (2) EP1845098A1 (da)
JP (1) JP5091944B2 (da)
KR (1) KR20090008275A (da)
CN (1) CN101448831B (da)
AR (1) AR060212A1 (da)
AT (1) ATE471325T1 (da)
AU (1) AU2007231362B2 (da)
BR (1) BRPI0709207A2 (da)
CA (1) CA2647116C (da)
CY (1) CY1111211T1 (da)
DE (1) DE602007007203D1 (da)
DK (1) DK2010536T3 (da)
ES (1) ES2347182T3 (da)
MX (1) MX2008012274A (da)
NO (1) NO20084375L (da)
PL (1) PL2010536T3 (da)
PT (1) PT2010536E (da)
RU (1) RU2486188C9 (da)
SI (1) SI2010536T1 (da)
TW (1) TWI403512B (da)
WO (2) WO2007110437A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2555263A1 (en) * 2004-02-12 2005-09-01 Neurogen Corporation Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
PE20121506A1 (es) 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
FR2918061B1 (fr) 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
JPWO2009057577A1 (ja) * 2007-10-30 2011-03-10 日本メジフィジックス株式会社 新規アミロイド親和性化合物の使用及び製造方法
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
CA2710016A1 (en) * 2007-12-21 2009-07-02 The University Of Sydney Translocator protein ligands
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
AU2009249186B2 (en) * 2008-05-19 2014-05-22 Sunovion Pharmaceuticals Inc. Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators
CN102131801B (zh) 2008-06-25 2015-04-08 福拉姆医药股份有限公司 1,2-二取代的杂环化合物
US20100267730A1 (en) * 2008-10-09 2010-10-21 Giuseppe Alvaro Novel compounds
SI2617420T1 (sl) 2009-05-07 2016-02-29 Forum Pharmaceuticals Inc. Fenoksimetil heterociklične spojine
TWI617559B (zh) * 2010-12-22 2018-03-11 江蘇恆瑞醫藥股份有限公司 ２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
UA112028C2 (uk) * 2012-12-14 2016-07-11 Пфайзер Лімітед Похідні імідазопіридазину як модулятори гамка-рецептора
GB201321734D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
DE3542661A1 (de) * 1985-12-03 1987-06-04 Bayer Ag Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung
DE8808030U1 (de) * 1987-07-04 1988-11-03 Krones Ag Hermann Kronseder Maschinenfabrik, 8402 Neutraubling Etikettiervorrichtung für Behälter
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
AU7079998A (en) * 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Condensed pyridazine derivatives, their production and use
AU746866B2 (en) * 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
ATE256128T1 (de) * 1998-10-21 2003-12-15 Takeda Chemical Industries Ltd Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung
KR100756592B1 (ko) * 1999-10-08 2007-09-10 그뤼넨탈 게엠베하 비사이클릭 이미다조-3-일-아민 유도체, 이의 제조방법 및 이를 포함하는 진통제
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
JP2002371042A (ja) * 2001-06-12 2002-12-26 Takeda Chem Ind Ltd ジアミン化合物、その製造法および用途
ES2276048T3 (es) * 2002-03-05 2007-06-16 Eli Lilly And Company Derivados de purina como inhibidores de cinasa.
GB0210124D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
WO2004058758A1 (en) * 2002-12-18 2004-07-15 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
MX2007005611A (es) * 2004-11-11 2007-07-11 Ferrer Int Compuestos de imidazo[1,2-a]piridina, composiciones, usos y metodos relacionados.
EP1848420A4 (en) * 2005-01-28 2008-01-23 Merck & Co Inc POLYMORPH SHAPES OF A GABAA AGONIST
EP1803722A1 (en) * 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
US20090318410A1 (en) * 2006-10-30 2009-12-24 Novartis Ag Imidazopyridazines as lipid kinase inhibitors

Also Published As

Publication number Publication date
RU2008142841A (ru) 2010-05-10
WO2007110438A1 (en) 2007-10-04
RU2486188C2 (ru) 2013-06-27
PT2010536E (pt) 2010-09-03
TW200813062A (en) 2008-03-16
EP1845098A1 (en) 2007-10-17
EP2010536B1 (en) 2010-06-16
RU2486188C9 (ru) 2013-08-10
US8993562B2 (en) 2015-03-31
US20090176788A1 (en) 2009-07-09
HK1127917A1 (en) 2009-10-09
AR060212A1 (es) 2008-06-04
TWI403512B (zh) 2013-08-01
JP2009531384A (ja) 2009-09-03
ES2347182T3 (es) 2010-10-26
US8153789B2 (en) 2012-04-10
ATE471325T1 (de) 2010-07-15
EP2010536A1 (en) 2009-01-07
JP5091944B2 (ja) 2012-12-05
US20120040979A1 (en) 2012-02-16
CY1111211T1 (el) 2015-06-11
CA2647116C (en) 2013-12-31
CN101448831A (zh) 2009-06-03
DE602007007203D1 (de) 2010-07-29
PL2010536T3 (pl) 2010-11-30
WO2007110437A1 (en) 2007-10-04
CN101448831B (zh) 2013-05-01
AU2007231362B2 (en) 2012-07-19
AU2007231362A1 (en) 2007-10-04
MX2008012274A (es) 2008-11-12
SI2010536T1 (sl) 2010-10-29
NO20084375L (no) 2008-10-17
CA2647116A1 (en) 2007-10-04
KR20090008275A (ko) 2009-01-21
BRPI0709207A2 (pt) 2011-06-28

Similar Documents

Publication Publication Date Title
DK2229391T3 (da) Pyrido[2,3-B]pyrazin-8-substituerede forbindelser og deres anvendelse
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
SI2010536T1 (sl) Imidazo(1,2-b)piridazini, postopki za njihovo pripravo in njihova uporaba kot GABA receptorski ligandi
DK1888580T3 (da) Pyrido[2,3-D]pyrimidiner, der er egnede som HCV-hæmmere, og fremgangsmåde til fremstillingen af disse
DOP2007000080A (es) Piridin [3,4-b] pirazinonas
DK2137184T3 (da) Imidazo[1,2-a]pyridinforbindelser som receptor-tyrosinkinaseinhibitorer
ZA200810161B (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
DK1973910T3 (da) Pyrrolo[3,2-c]pyridin-4-on-2-indolinon-proteinkinaseinhibitorer
DK2004654T3 (da) Pyrazolopyrimidin derivater til anvendelse som kinase antagonister
SI1893612T1 (sl) Pirolo b piridin derivati kot protein kinazni inhibitorji
DK2124944T3 (da) Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
ZA200806809B (en) Pyridine-2-carboxamide derivatives
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
IL198244A0 (en) Pyridazine derivatives
ZA200901128B (en) Spirocyclic azaindole derivatives
DE102008005493A8 (de) 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
DK2087890T3 (da) Præparat med vedvarende frigørelse til vævsregenereringsterapi
DK2041069T3 (da) Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler
IL179603A0 (en) Pyrrolopyridine derivatives
DK2167470T3 (da) Triazolo-[1,5A]-chinoliner som adenosin-A3-receptor ligander
PL1988090T3 (pl) Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie
DK2064185T3 (da) 1H-quinolin-4-on-forbindelser med affinitet til GABA-receptoren, fremgangsmåder, anvendelser og sammensætninger
GB2433993B (en) Single molecule TR-FRET probe
DK2059521T3 (da) Pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelse og sammensætninger
DK1951699T3 (da) Fremgangsmåder til fremstilling af cyclopropylamidderivater